🚀

오늘의 열정을 계속 이어가세요!

체험은 만족하셨나요? 지식 자료를 소장하고 멋진 의료인으로 성장하세요!

구경하기
Medications Used to Manage Postpartum Hemorrhage | 마이메르시 MyMerci
제안하기

뭔가 하고 싶은 말이 있는거야?

제안하기
닫기
컨텐츠 수정하기

컨텐츠 내용을 수정할 수 있습니다

수정하기
닫기

Medications Used to Manage Postpartum Hemorrhage

NCLEX Review Guide: Ergot Alkaloids for Postpartum Hemorrhage

Pharmacology Basics

Mechanism of Action

  • Ergot alkaloids (ergonovine, methylergonovine) directly stimulate smooth muscle contractions in the uterus by activating alpha-adrenergic receptors. This results in sustained tetanic uterine contractions that help control bleeding by compressing blood vessels within the myometrium.
  • Unlike oxytocin which causes rhythmic contractions, ergot alkaloids produce sustained contractions that last 45 minutes to 3 hours, making them effective for controlling persistent postpartum hemorrhage.

Key Points

  • Ergot alkaloids cause tetanic (sustained) uterine contractions, not rhythmic ones
  • Primary mechanism: alpha-adrenergic stimulation of smooth muscle
  • Longer duration of action compared to oxytocin

Common Medications

  • Methylergonovine (Methergine): Most commonly used ergot alkaloid in the US, administered 0.2 mg IM every 2-4 hours for a maximum of 5 doses to control postpartum hemorrhage after delivery of the placenta.
  • Ergonovine (Ergotrate): Less frequently used, can be administered 0.2 mg IM every 2-4 hours for a maximum of 5 doses.

Key Points

  • Methylergonovine (Methergine) is the preferred ergot alkaloid in clinical practice
  • Typical dose: 0.2 mg IM every 2-4 hours (max 5 doses)
  • IV administration is possible but should be done slowly, diluted, and only in emergencies

Clinical Applications

Indications

  • Primary indication is management of postpartum hemorrhage due to uterine atony after delivery of the placenta. Ergot alkaloids are typically used as second-line agents when oxytocin fails to adequately control bleeding.
  • May be used prophylactically in patients with high risk for postpartum hemorrhage, such as grand multiparity, prolonged labor, chorioamnionitis, or history of previous postpartum hemorrhage.

Key Points

  • Used for postpartum hemorrhage due to uterine atony
  • Second-line after oxytocin failure
  • Only administered after placental delivery (never before)

Administration

  1. Confirm placenta has been delivered completely (ergot alkaloids are contraindicated before placental delivery)
  2. Assess for contraindications (hypertension, preeclampsia, cardiovascular disease)
  3. Administer methylergonovine 0.2 mg IM as ordered
  4. Monitor vital signs, especially blood pressure, every 15 minutes for the first hour
  5. Assess uterine tone and vaginal bleeding
  6. Document medication administration, patient response, and bleeding status

Clinical Scenario: A 28-year-old G3P3 woman has delivered a healthy baby 30 minutes ago. Despite active management of the third stage with oxytocin, her uterus remains boggy with estimated blood loss of 800 mL. After confirming normal blood pressure (118/72 mmHg) and complete placental delivery, methylergonovine 0.2 mg IM is administered. Within 10 minutes, her uterus becomes firm and bleeding decreases significantly.

Key Points

  • IM route is preferred for safety; IV administration carries higher risk
  • Monitor vital signs closely after administration
  • Assess uterine tone and bleeding response

Contraindications and Precautions

Absolute Contraindications

  • NEVER administer before delivery of the placenta as it can cause tetanic uterine contractions that trap the placenta or cause uterine rupture.
  • Contraindicated in patients with hypertension, preeclampsia/eclampsia, cardiovascular disease, or peripheral vascular disease due to significant vasoconstrictive effects.
  • Also contraindicated in patients with hepatic or renal impairment, as metabolism and excretion of the drug may be affected, increasing risk of toxicity.

Key Points

  • Absolutely contraindicated before placental delivery
  • Never use in hypertensive disorders of pregnancy
  • Avoid in patients with cardiovascular or peripheral vascular disease

Adverse Effects

  • Hypertension: Most serious side effect due to peripheral vasoconstriction. Can lead to stroke, seizures, or myocardial infarction in severe cases.
  • Nausea and vomiting: Common side effects that occur in approximately 10-15% of patients.
  • Other adverse effects include headache, dizziness, tinnitus, chest pain, dyspnea, and palpitations.

Key Points

  • Hypertension is the most serious adverse effect
  • Monitor blood pressure closely during administration
  • Stop medication immediately if severe hypertension occurs

Commonly Confused Points

Ergot Alkaloids vs. Other Uterotonics

Characteristic Ergot Alkaloids (Methylergonovine) Oxytocin Prostaglandins (Misoprostol)
Type of contractions Tetanic (sustained) Rhythmic Tetanic and rhythmic
Onset of action 2-5 minutes (IM) Immediate (IV), 3-5 min (IM) 8-20 minutes
Duration 45 min - 3 hours 30-60 minutes 3-5 hours
Route Primarily IM (IV only in emergencies) IV, IM PO, SL, PR, buccal
Major contraindication Hypertension, preeclampsia Few absolute contraindications Asthma, glaucoma
Line of therapy Second-line First-line Third-line

Key Points

  • Oxytocin is always first-line therapy for PPH
  • Ergot alkaloids cause sustained contractions vs. rhythmic with oxytocin
  • Ergot alkaloids have more cardiovascular side effects than oxytocin

Common Misconceptions

Remember the "ERGOT" Rule

  • E - Exclude hypertension before giving
  • R - Retained placenta is a contraindication
  • G - Give IM (not IV) when possible
  • O - Oxytocin should be tried first
  • T - Tetanic contractions are produced

Common Pitfalls

  • Administering ergot alkaloids before placental delivery
  • Using in patients with hypertension or preeclampsia
  • Failing to monitor blood pressure after administration
  • Administering IV without proper dilution and slow infusion
  • Using as first-line therapy instead of oxytocin

Study Tips

Memory Aids

Contraindications Mnemonic: "HEAT"

  • Hypertension/preeclampsia
  • Ergot alkaloids don't mix
  • After placenta only (never before)
  • Thrombotic disorders/vascular disease

Adverse Effects Mnemonic: "ERGOT PAINS"

  • Elevated blood pressure
  • Rapid heartbeat
  • GI upset (nausea/vomiting)
  • Obscured vision
  • Tinnitus
  • Pain (headache)
  • Angina (chest pain)
  • Inability to breathe normally (dyspnea)
  • Numbness or tingling in extremities
  • Seizures (in severe cases)

NCLEX Practice Questions

Question 1: A nurse is preparing to administer methylergonovine (Methergine) to a postpartum patient with uterine atony. Which assessment finding would be an absolute contraindication to this medication?

A. Blood pressure of 150/92 mmHg

B. Heart rate of 110 beats per minute

C. Temperature of 100.4°F (38°C)

D. Respiratory rate of 22 breaths per minute

Answer: A. Blood pressure of 150/92 mmHg

Rationale: Hypertension is an absolute contraindication to ergot alkaloids due to their vasoconstrictive effects which can further increase blood pressure.

Question 2: A nurse is administering methylergonovine (Methergine) to a patient with postpartum hemorrhage. Which of the following indicates the nurse understands the appropriate administration of this medication?

A. "I will administer this medication before delivery of the placenta to prevent hemorrhage."

B. "I will administer this medication intravenously as a rapid bolus for quick effect."

C. "I will monitor the patient's blood pressure every 15 minutes after administration."

D. "I will administer this as the first-line medication for postpartum hemorrhage."

Answer: C. "I will monitor the patient's blood pressure every 15 minutes after administration."

Rationale: Close monitoring of blood pressure is essential after administering ergot alkaloids due to their vasoconstrictive effects. The medication should only be given after placental delivery, is typically given IM (not IV bolus), and is used as a second-line agent after oxytocin.

Self-Assessment Checklist

  • I can explain the mechanism of action of ergot alkaloids
  • I can list the absolute contraindications to ergot alkaloids
  • I understand the difference between ergot alkaloids and oxytocin
  • I know the proper dosage and administration route for methylergonovine
  • I can identify the major adverse effects of ergot alkaloids
  • I understand why ergot alkaloids should never be given before placental delivery
  • I know the nursing assessments required before and after administering ergot alkaloids
  • I can explain when ergot alkaloids would be indicated in postpartum hemorrhage management

Summary of Key Points

  • Mechanism: Ergot alkaloids cause sustained tetanic uterine contractions through alpha-adrenergic stimulation.
  • Primary Use: Second-line treatment for postpartum hemorrhage due to uterine atony after placental delivery.
  • Common Agent: Methylergonovine (Methergine) 0.2 mg IM every 2-4 hours (maximum 5 doses).
  • Key Contraindications: Hypertension, preeclampsia, cardiovascular disease, retained placenta.
  • Major Side Effect: Hypertension due to vasoconstriction.
  • Critical Nursing Action: Monitor blood pressure closely after administration.
  • Administration Timing: ONLY after confirmed complete delivery of the placenta.
  • Comparison: Produces tetanic contractions (vs. rhythmic with oxytocin) with longer duration of action.

IMPORTANT SAFETY ALERT: Never administer ergot alkaloids to patients with hypertension, preeclampsia, or before placental delivery. These situations can lead to severe complications including stroke, seizures, or uterine rupture.

Remember, understanding the proper use of ergot alkaloids is critical for safe maternal care. While they are powerful tools for managing postpartum hemorrhage, their contraindications and side effects require careful consideration. You've got this! Every medication you master brings you one step closer to providing excellent nursing care.

다음 이론을 계속 학습하려면 로그인하세요.

로그인하고 계속 학습
컨텐츠를 그만볼래?

필기노트, 하이라이터, 메모는 잘 쓰고 있어?

내보내줘
어떤 폴더에 저장할래?

컨텐츠 노트에는 총 0개의 폴더가 있어!

폴더 만들기
컨텐츠 만들기
만들기
신고했어요.

운영진이 검토할게요!

해당 유저를 차단했어요.

마이페이지에서 차단한 회원을 관리할 수 있어요.